Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > Portugal & Spain

Find below news from the Portugal and Spain. Listed are news about these countries as well as from organisations located there.

Total search results: 405 | Ordered by Source (ascending)
1 2 3 4 5  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
2B BlackBio S.L.. (10/25/11). "Press Release: BlackBio Gets more than 2 Million Euros after Capital Increase and Public Funding". 2011-10-25
2B BlackBio S.L.. (2/15/10). "Press Release: BlackBio, Making Personalized Medicine a Reality. Established in 2009 BlackBio Is a Biotechnology Spin-off Company Committed to Making Personalized Medicine an Affordable Reality". 2010-02-15
2B BlackBio S.L.. (2/27/12). "Press Release: The Spanish Biotechnological Companies, Biotools and 2B BlackBio, Reach an Agreement with the Mexican Pharmaceutics Silanes Laboratories". 2012-02-27
3P Biopharmaceuticals S.L.. (12/20/13). "Press Release: Dámaso Molero, a New Member of the Board of Directors of Asebio". 2013-12-20
3P Biopharmaceuticals S.L.. (4/14/14). "Press Release: 3P Biopharmaceuticals Invests 630,000€ in Increasing Its Capacity Development". 2014-04-14
3P Biopharmaceuticals S.L.. (4/23/15). "Press Release: 3P Biopharmaceuticals Produces a Cellular Drug for the First Clinical Trial of Acute Myocardial Infarction with Allogeneic Cardiac Stem Cells". 2015-04-23
3P Biopharmaceuticals S.L.. (5/5/15). "Press Release: 3P Biopharmaceuticals Acquires a Mass Spectrometer". 2015-05-05
3P Biopharmaceuticals S.L.. (7/10/13). "Press Release: 3P Biopharmaceuticals Will Participate in a Major European Project Aiming to Develop a Universal Influenza Virus Vaccine". 2013-07-10
4DCell Fate Project. (2/13/12). "Press Release: Cell Fate in 4D. Bringing together European Excellence to Uncover the Mechanisms at Work that Determine Cell Fate". Barcelona. 2012-02-13
4SC AG. (6/23/11). "Press Release: 4SC Reports New Data from the Clinical Trials with Oral Pan-HDAC Inhibitor Resminostat. Update on Phase II SHELTER and Phase I/II SHORE Trials". Planegg-Martinsried. 2011-06-23
AB Sciex. (1/22/15). "Press Release: European Reference Laboratory Improves Accuracy of Pesticide Detection in Food with AB SCIEX Mass Spectrometry Instrumentation". Warrington. 2015-01-22
AB Sciex. (11/8/12). "Press Release: AB Sciex, Phenomenex and Peak Scientific Take Mobile Laboratory on European MASStatic Voyage Tour. Mobile Lab Will Stop at EBF Conference in Barcelona Next Week to Demonstrate LC/MS/MS Workflows". Framingham, MA. 2012-11-08
AB-Biotics S.A.. (10/2/13). "Press Release: AB-Biotics and Scienta Farma Partner to Sell a Pharmacogenetic Test in Mexico". Barcelona. 2013-10-02
AB-Biotics S.A.. (10/28/13). "Press Release: AB-Biotics Acquires a Patent for Predicting Antipsychotic-induced Extrapyramidal Symptoms". Barcelona. 2013-10-28
AB-Biotics S.A.. (11/7/12). "Press Release: AB-Biotics Signs Agreement with HanAll BioPharma to Distribute Its Cholesterol-lowering Probiotic in Korea". Barcelona. 2012-11-07
AB-Biotics S.A.. (2/28/12). "Press Release: AB-Biotics Sign Licensing Agreements on Cholesterol-lowering Probiotic for Southeast Europe and Spain". 2012-02-28
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Ability Pharmaceuticals S.L.. (11/22/16). "Press Release: Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First Line Therapy in Patients with Endometrial or Squamous Lung Cancer". Barcelona. 2016-11-22
Ability Pharmaceuticals S.L.. (2/5/13). "Press Release: Ability Pharmaceuticals Awarded a 1.2 Million Euros Grant to Develop Its Lipid Analog ABTL0812 for Lung and Pancreatic Cancer. The Grant Will Fund the First-in-Man Phase Ib Clinical Trial". Bellater 2013-02-05
Ability Pharmaceuticals S.L.. (4/7/15). "Press Release: Ability Pharmaceuticals Receives Positive Opinion from EMA for Orphan Drug Status of ABTL0812 in Pediatric Cancer Neuroblastoma". Barcelona. 2015-04-07
Ability Pharmaceuticals S.L.. (9/18/17). "Press Release: Ability Pharmaceuticals Announces EMA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer". Barcelona. 2017-09-18
Ability Pharmaceuticals S.L.. (9/21/12). "Press Release: AB-Therapeutics Closes 1 Million Euro Financing Round and Changes the Company Name to Ability Pharmaceuticals". Bellaterra (Barcelona). 2012-09-21
Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. 2017-12-07
Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. 2017-05-02
Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. 2017-09-18
Accovion GmbH. (6/22/12). "Press Release: Accovion GmbH further Expands Global Presence. Accovion Launches New Subsidiary in Spain". Eschborn. 2012-06-22
Actavis, Inc.. (8/6/13). "Press Release: Actavis Acquires Worldwide Rights for Palau Pharma’s Albaconazole Antifungal Agent". Parsippany, NJ & Barcelona. 2013-08-06
Advanced Chemistry Development, Inc. (ACD/Labs). (3/20/18). "Press Release: ACD/Labs Files Lawsuit for Copyright Infringement against MestreLab Research". Toronto. 2018-03-20
Advancell. (03/14/2011). "Press Release: Biotech Companies Advancell, Neurotec Pharma and Aromics, Have Created the Consortium MSALS – in Order to Develop a New Treatment for Multiple Sclerosis". Barcelona. 2011-03-14
Advancell. (09.07.2013). "Press Release: Helsinn and Advancell Sign a Partnering Agreement for ATH008, a New Compound for Chemotherapy-induced Dermatological Injuries". Barcelona. 2013-07-09
Advancell. (14.03.2011). "Press Release: Advancell and Leitat Join Forces to Promote Cell Reagents through the New Company, ReadyCell". Barcelona. 2011-03-14
Advancell. (14.03.2011). "Press Release: Advancell Announces Promising Phase I/IIa Results with Acadra in CLL". Barcelona. 2011-03-14
Advancell. (17.05.2011). "Press Release: Advancell Announces the Initiation of a Clinical Phase IIb Study of ATH008 in Hand-Foot Syndrome (or Palmar-Plantar Erythrodysesthesia Syndrome)". Barcelona. 2011-05-17
Advancell. (19.09.2011). "Press Release: Start of In-patient Clinical Trials with NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis without Immunosuppressive Effects". Barcelona. 2011-09-19
Advion, Inc.. (2/14/13). "Press Release: Konik Named as Advion’s Compact Mass Spectrometer (CMS) Distributor in Spain, Portugal and many South American Countries". Ithaca, NY. 2013-02-14
Aelix Therapeutics S.L.. (1/11/16). "Press Release: Aelix Therapeutics Completes Series A Funding of €11.5m ($12.7m) for Therapeutic HIV Vaccine". Barcelona. 2016-01-16
Aelix Therapeutics S.L.. (10/18/18). "Press Release: Aelix Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure". 2018-10-18
Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". 2017-10-20
Aelix Therapeutics S.L.. (9/5/17). "Press Release: Aelix Therapeutics Enrolls First Patient in Company’s Initial Therapeutic HIV Vaccine Clinical Trial". 2017-09-05
Agilent Technologies Inc.. (10/30/12). "Press Release: Agilent Technologies and Spain’s Centre for Omic Sciences to Collaborate on Integrated Systems Biology Research, Establish Centre of Excellence". Tarragona & Santa Clara, CA. 2012-10-30
Agilent Technologies Inc.. (8/27/13). "Press Release: Agilent Technologies to Sponsor Global Forensics Congress in Portugal". Santa Clara, CA. 2013-08-27
AiCuris GmbH & Co. KG. (4/2/12). "Press Release: Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients of Human Blood Precursor Cell Transplants Meeting both Primary Efficacy Endpoints to Be Presented at Internatio 2012-04-02
Algenex S.L.. (3/5/19). "Press Release: Algenex Closes Funding Round and Strengthens Team with Key Senior Manager Appointments". Madrid. 2019-03-05
Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. 2017-03-13
Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results". 2017-09-28
Almirall S.A.. (01.04.2014). "Press Release: Forest Laboratories and Almirall Provide Update on the Fixed Dose Combination of Aclidinium and Formoterol in the U.S.". New York. 2014-04-01
Almirall S.A.. (1/25/12). "Press Release: Almirall and Galapagos Enter a Research Alliance. The Three-year Integrated Drug Discovery Alliance Is for Identigying Drug Development Candidates – Collaboration Is for Treating Respiratory Disease". Barcelona. 2012-01-25
Almirall S.A.. (10/23/12). "Press Release: Almirall Invests in Personalised Medicine by Becoming Part of the Share Capital of AB-Biotics". Barcelona. 2012-10-23
Almirall S.A.. (11/15/11). "Press Release: Almirall and BioFocus Announce Collaboration to Find New Hit Compounds against Key Targets. Targets Are Related to the Treatment of Respiratory and Inflammatory Conditions". Barcelona & Saffron Walden. 2011-11-15
Almirall S.A.. (11/15/12). "Press Release: 3rd Quarter Results. Q3 in Line, Eklria Now Availalbe to European Patients". Barcelona. 2012-11-15
Almirall S.A.. (11/16/11). "Press Release: Almirall Starts Phase III for Aclidinium and Formoterol in COPD. Almirall’s Respiratory Franchise Continues to Expand in COPD". Barcelona. 2011-11-16
Almirall S.A.. (11/19/12). "Press Release: Almirall Appoints Karin Louise Dorrepaal as New Independent Board Member. Karin Louise Dorrepaal Is the First Woman to Join Almirall’s Board of Directors, which Is Made up of Ten Members". Barcelona. 2012-11-19
Almirall S.A.. (11/28/12). "Press Release: Constella (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults". Barcelona & Cambridge, MA. 2012-11-28
Almirall S.A.. (11/3/14). "Press Release: Almirall Completes Deal with AstraZeneca in Respiratory Disease". Barcelona. 2014-11-03
Almirall S.A.. (11/30/15). "Press Release: Almirall Reaches an Agreement to Acquire 100% of Poli Group". Barcelona. 2015-11-30
Almirall S.A.. (12/11/12). "Press Release: Almirall and Forest Laboratories Announce Commercial Availability of Tudorza Pressair in U.S. Pharmacies". Barcelona. 2012-12-11
Almirall S.A.. (12/17/13). "Press Release: Almirall Reaches an Agreement to Acquire Aqua Pharmaceuticals, a US-based Specialty Dermatology Company". Barcelona. 2013-12-17
Almirall S.A.. (12/5/11). "Press Release: Almirall Launches Solaraze in Spain for the Treatment of Actinic Keratosis". Barcelona. 2011-12-05
Almirall S.A.. (12/5/13). "Press Release: Almirall Announces a Reorganization Program Affecting the Group in Europe". Barcelona. 2013-12-05
Almirall S.A.. (2/23/15). "Press Release: Almirall Full-year 2014 Results – in Line with Guidance". Barcelona. 2015-02-23
Almirall S.A.. (2/24/14). "Press Release: Almirall’s Full-year Results 2013 – Setting the Foundations for Accelerating Growth". Barcelona. 2014-02-24
Almirall S.A.. (2/3/14). "Press Release: Almirall Reaches an Agreement to Implement the Restructuring Plan in Spain". Barcelona. 2014-02-03
Almirall S.A.. (2/8/13). "Press Release: Almirall Commercialises Neurofarmagen, an Innovative Genetic Test". Barcelona. 2013-02-08
Almirall S.A.. (3/19/14). "Press Release: Almirall Completed Senior Notes Pricing of 325 Million Euros with a 7-year Maturity and 4.625% Annual Interest". Barcelona. 2014-03-19
Almirall S.A.. (4/1/14). "Press Release: InDex Pharmaceuticals and Almirall Enter into a License Agreement for European Rights of the Phase III Drug Candidate Kappaproct". Barcelona. 2014-04-01
Almirall S.A.. (4/16/13). "Press Release: Almirall and Forest Laboratories Announce Positive Results of a Phase III Study for Aclidinium and Formoterol Combination in COPD". Barcelona. 2013-04-16
Almirall S.A.. (5/6/13). "Press Release: Almirall Maintains its Shareholder Return Thanks to its R&D and Internationalisation Results". Barcelona. 2013-05-06
Almirall S.A.. (5/7/13). "Press Release: Almirall Begins the Transformation. Q1 Results on Track to Achieve Yearly Guidance". Barcelona. 2013-05-07
Almirall S.A.. (7/29/13). "Press Release: Almirall’s H1 – Executing on Growth Platforms, Financial Delivery on Track". Barcelona. 2013-07-29
Almirall S.A.. (7/29/15). "Press Release: Almirall Closes $15 Million Strategic Investment in Suneva Medical". Barcelona. 2015-07-29
Almirall S.A.. (7/30/12). "Press Release: Almirall’s H1. Strong Newsflow and Guidance Reiterated". Barcelona. 2012-07-30
Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona. 2017-08-28
Almirall S.A.. (9/25/14). "Press Release: Almirall's Aclidinium Bromide/Formoterol Fumarate Recommended for Approval in Europe to Treat COPD". Barcelona. 2014-09-25
Almirall S.A.. (9/5/13). "Press Release: International Pharmaceutical Company, Almirall, Expands Global Footprint with New Canadian Affiliate". Toronto. 2013-09-05
AM-Pharma B.V.. (9/13/11). "Press Release: AM-Pharma Raises €29.2m in Series D Financing". Bunnik. 2011-09-13
Amcure GmbH. (8/23/17). "Press Release: Amcure Announces Formation of Inaugural Scientific Advisory Board". Eggenstein-Leopoldshafen. 2017-08-23
Amsterdam Molecular Therapeutics. (10/29/09). "Press Release: AMT Starts Development of LPLChip with Progenika". Amsterdam. 2009-10-29
Amsterdam Molecular Therapeutics. (9/28/10). "Press Release: AMT’s Partner Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene". Amsterdam. 2010-09-28
Aphios Corporation. (6/12/13). "Press Release: Aphios USA and VivaCell Spain to Develop Novel Class of Compounds for Multiple Sclerosis and CNS Disorders". Woburn, MA. 2013-06-12
Applied Photophysics Ltd.. (5/15/18). "Press Release: Applied Photophysics Signs Agreements with Alfatest and Paralab to Expand Distribution in Europe". Surrey, Rome & Valborn. 2018-05-15
AptaTargets. (5/17/17). "Press Release: AptaTargets Closes €2.7 Million Round of Funding for New Stroke Treatment". Madrid. 2017-05-17
Archivel. (01/15/2012). "Press Release: Archivel Secures Funding to Bring the Antituberculosis Therapeutic Vaccine RUTI to Market". Barcelona. 2012-01-15
Argen-X B.V.. (3/1/10). "Press Release: Argen-X SIMPLE Antibody Platform Set to Transform Therapeutic Antibody Discovery and Development". Rotterdam. 2010-03-01
Bayer AG. (6/25/09). "Press Release: Development of Vegetable Seed Varieties for the Mediterranean Basin. Bayer CropScience Unit Nunhems Opens Research & Development Station in La Palma-Cartagena/Spain". Monheim. 2009-06-25
Bayer AG. (6/28/16). "Press Release: Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer [Not intended for U.S. and UK Media]". Berlin. 2016-06-28
BEAM Alliance. (6/9/15). "Press Release: Launch of the BEAM Alliance – Europe’s Combined Action against Antimicrobial Resistance. Biotechs from Europe Innovating in Anti-microbial Resistance". 2015-06-09
Biocat. (1/12/12). "Press Release: Intelligent Pharma Opens Subsidiary in United States. This New Subsidiary, Based in Cambridge (Massachusetts), Is the Third International Office This Biotech Company Has Opened in Less than Two years". 2012-01-12
Biocat. (1/27/16). "Press Release: GoodGut Gets €615,000 to Research Ways to Detect Colon Cancer and Crohn’s". 2016-01-27
Biocat. (11/27/14). "Press Release: Phyture Biotech Signs Distribution Contract, Moving into 11 Markets in Europe and Latin America. InKemia IUCT Group Holds 21% of the Company’s Equity". 2014-11-27
Biocat. (11/8/11). "Press Release: Bilbao, Will Be the Venue for Biospain 2012. Biospain Is the Presentation Platform for the Spanish Biotechnology at an International Level". 2011-11-08
Biocat. (12/20/12). "Press Release: In Depth > TT Success Story. iMicroQ to Launch Rapid-detection Kit for Salmonella". 2012-12-20
Biocat. (3/20/12). "Press Release: Barcelona to Host BIO-Europe Spring, Top European Biotechnology Congress, again in 2013". 2012-03-20
Biocat. (3/20/12). "Press Release: Salvador Maluquer, New General Director of Barcelona Science Park". 2012-03-20
Biocat. (4/26/13). "Press Release: Catalonia Receives European Funding to Continue Efforts to Bring Health Research to Patients". 2013-04-26
Biocat. (5/19/16). "Press Release: IDP Pharma Raises €2 Millions to Develop IDP Protein Drugs". Basel. 2016-05-19
Biocat. (5/6/13). "Press Release: iMicroQ Gets One Million Euros to Begin Manufacturing Innovative Salmonella Detection Kit. Caixa Capital Has Led the Round of Funding". 2013-05-06
Biocat. (6/10/11). "Press Release: Intelligent Pharma Opens Its Second Subsidiary Office in Europe. It Is Located in Hertforshire (United Kingdom) at the BioPark Cluster, Only a Year Later After the Opening of Its First International Office in Germany". 2011-06-10
Biocat. (8/29/11). "Press Release: AB-Biotics Starts Up Expansion Plan for United States, Europe and Latin America. This Biotech Company Is Preparing a Capital Increase to Fund Their Positioning Abroad". 2011-08-29
BioClin Therapeutics, Inc.. (3/22/17). "Press Release: BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital". San Ramon, CA. 2017-03-22
Biocrates Life Sciences AG. (2/6/12). "Press Release: Biocrates Goes Spain and Turkey. Austrian Diagnostic Expert in Personalized Medicine Coninues to Expand Its European Distribution Network". 2012-02-06
1 2 3 4 5  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top